— Know what they know.
Not Investment Advice
Also trades as: PAX.ST (STO) · $vol 0M

PXMBF OTC

Paxman AB (publ)
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -51.0% 5Y: +70.7%
$3.50
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 40 · $81.5M mcap · 14M float · 0.0037% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$313M +23.5% ▲
5Y CAGR: +32.0%
Gross Profit
$4M -97.6% ▼
5Y CAGR: -39.1%
Operating Income
$4M -87.3% ▼
Net Income
-$17M -141.5% ▼
EPS (Diluted)
$-0.76 -136.0% ▼
EBITDA
$28M -42.9% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$96M$157M$221M$253M$313M
YoY Growth+23.3%+62.9%+40.7%+14.7%+23.5%
Cost of Revenue$32M$55M$74M$78M$308M
Gross Profit$65M$101M$146M$175M$4M
Gross Margin67.1%64.7%66.4%69.3%1.4%
R&D Expenses$2M$2M$0$0$0
SG&A Expenses$29M$85M$59M$68M$0
Operating Expenses$75M$103M$134M$142M$0
Operating Income-$11K-$1M$13M$34M$4M
Operating Margin-0.0%-0.8%5.7%13.2%1.4%
Interest Expense$2M$7M$5M$1M$15M
Income Before Tax-$13M-$9M$8M$42M-$11M
Tax Expense$106K$2M-$361K$1M$6M
Net Income-$13M-$10M$8M$40M-$17M
Net Margin-13.3%-6.6%3.8%15.9%-5.3%
EPS (Diluted)$-0.73$-0.54$0.44$2.11$-0.76
EBITDA$3M$14M$31M$50M$28M
Shares Outstanding17M19M19M19M22M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms